During the pandemic, our foundation has intensified its commitment to investing in researchers and innovation ecosystems in low- and middle-income countries. This includes the next generation of Grand Challenges grants:…
In July 2023, Revital Healthcare became the first-ever African manufacturer approved by the WHO to produce early activation auto-disable syringes—a milestone that will help diversify the geographic supplier base of…
The foundation has committed up to US$120 million to help ensure equitable global distribution of a promising new COVID-19 drug, molnupiravir. Here’s why that drug may be a game-changer in…
We know how to make smart investments in equitable economic recovery. If the IMF and the international community fail to act now, decades of development progress will be lost.
The 11 grantees of the Gates Foundation’s first U.S. education Grand Challenge will design and implement innovative solutions to make algebra more accessible and relevant to students of color, English…
We already have the breakthrough technologies needed to provide safe and affordable sanitation services to the billions of people who are at risk of waste-borne diseases. Building markets and attracting…
Now is the time to support developing countries in building the infrastructure, skills, and systems they need to develop safe and affordable vaccines for diseases that mostly affect poorer nations.
In the race against the coronavirus and its variants, wealthier countries must meet their vaccine-sharing commitments faster and pledge a greater share of their supply to low- and middle-income countries.
Data collected during the pandemic show just how much worse women have fared economically than men. Without urgent action, they will only fall further behind during the recovery.
